Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer

Journal of Thoracic and Cardiovascular Surgery

Volumn 140, Issue 2, 2010, Pages 377-386

  Crabtree, Traves D ^a   Denlinger, Chadrick E ^a   Meyers, Bryan F ^a   El Naqa, Issam ^a   Zoole, Jennifer ^a   Krupnick, A Sasha ^a   Kreisel, Daniel ^a   Patterson, G Alexander ^a   Bradley, Jeffrey D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ACE 27; Adult Co Morbidity Evaluation 27; computed tomograph; CT; FEV 1; forced expiratory volume in 1 second; non small cell lung cancer; NSCLC; PET; positron emission tomography; propensity score matching; PSM; SBRT; stereotactic body radiation therapy

Indexed keywords

CARBON MONOXIDE;

AGE; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RATING SCALE; STEREOTACTIC BODY RADIATION THERAPY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PNEUMONECTOMY; POSITRON-EMISSION TOMOGRAPHY; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; RADIOSURGERY; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 77955468519     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2009.12.054     Document Type: Article

References (24)

1. R.C. McGarry, G. Song, P. des Rosieres, and R. Timmerman Observation-only management of early stage, medically inoperable lung cancer: poor outcome Chest 121 2002 1155 1158
2. D.J. Raz, J.A. Zell, S.H. Ou, D.R. Gandara, H. Anton-Culver, and D.M. Jablons Natural history of stage I non-small cell lung cancer: implications for early detection Chest 132 2007 193 199
3. P. Baumann, J. Nyman, M. Hoyer, G. Gagliardi, I. Lax, and B. Wennberg et al. Stereotactic body radiotherapy for medically inoperable patients with stage I nonsmall cell lung cancer - a first report of toxicity related to COPD/CVD in a nonrandomized prospective phase II study Radiother Oncol 88 2008 359 367
4. F.J. Lagerwaard, C.J. Haasbeek, E.F. Smit, B.J. Slotman, and S. Senan Outcomes of risk adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer Int J Radiat Oncol Biol Phys 70 2008 685 692
5. H. Onishi, H. Shirato, Y. Nagata, M. Hiraoka, M. Fujino, and K. Gomi et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study J Thorac Oncol 2 7 Suppl. 3 2007 S94 100
6. R. Timmerman, L. Papiez, R. McGarry, L. Likes, C. DesRosiers, and S. Frost et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer Chest 124 2003 1946 1955
7. R. Onimaru, H. Shirato, S. Shimizu, K. Kitamura, B. Xu, and S. Fukumoto et al. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers Int J Radiat Oncol Biol Phys 56 2003 126 135
8. M. Uematsu, A. Shioda, A. Suda, T. Fukui, Y. Ozeki, and Y. Hama et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience Int J Radiat Oncol Biol Phys 51 2001 666 670
9. P. Goldstraw, J. Crowley, K. Chansky, D.J. Giroux, P.A. Groome, and R. Rami-Porta et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours J Thorac Oncol 2 2007 706 714
10. X. Qiao, O. Tullgren, I. Lax, F. Sirzen, and R. Lewensohn The role of radiotherapy in treatment of stage I non-small cell lung cancer Lung Cancer 41 2003 1 11
11. S. Kang, R. Luo, W. Liao, H. Wu, X. Zhang, and Y. Meng Single group study to evaluate the feasibility and complications of radiofrequency ablation and usefulness of post treatment position emission tomography in lung tumours World J Surg Oncol 2 2004 30
12. A. Pennathur, J.D. Luketich, G. Abbas, M. Chen, H.C. Fernando, and W.E. Gooding et al. Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients J Thorac Cardiovasc Surg 134 2007 857 864
13. J. Sakurai, T. Hiraki, T. Mukai, H. Mimura, K. Yasui, and H. Gobara et al. Intractable pneumothorax due to bronchopleural fistula after radiofrequency ablation of lung tumors J Vasc Interv Radiol 18 2007 141 145
14. C.J. Simon, and D.E. Dupuy Current role of image-guided ablative therapies in lung cancer Expert Rev Anticancer Ther 5 2005 657 666
15. T. Yamagami, T. Kato, T. Hirota, R. Yoshimatsu, T. Matsumoto, and T. Nishimura Pneumothorax as a complication of percutaneous radiofrequency ablation for lung neoplasms J Vasc Interv Radiol 17 2006 1625 1629
16. R.J. Ginsberg, and L.V. Rubinstein Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group Ann Thorac Surg 60 1995 615 622
17. A. Kilic, M.J. Schuchert, B.L. Pettiford, A. Pennathur, J.R. Landreneau, and J.P. Landreneau et al. Anatomic segmentectomy for stage I non-small cell lung cancer in the elderly Ann Thorac Surg 87 2009 1662 1666
18. A. El-Sherif, W.E. Gooding, R. Santos, B. Pettiford, P.F. Ferson, and H.C. Fernando et al. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis Ann Thorac Surg 82 2006 408 415
19. T.J. Birdas, R.P. Koehler, A. Colonias, M. Trombetta, R.H. Maley Jr., and R.J. Landreneau et al. Sublobar resection with brachytherapy versus lobectomy for stage Ib nonsmall cell lung cancer Ann Thorac Surg 81 2006 434 438
20. 125Iodine brachytherapy after sublobar resection in high-risk patients with Stage I non-small-cell lung cancer Surgery 134 2003 691 697
21. H. Hof, M. Muenter, D. Oetzel, A. Hoess, J. Debus, and K. Herfarth Stereotactic singledose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC) Cancer 110 2007 148 155
22. M.S. Allen, G.E. Darling, T.T. Pechet, J.D. Mitchell, J.E. Herndon, and R.J. Landreneau et al. Morbidity and mortality of major pulmonary resections in patients with earlystage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial Ann Thorac Surg 81 2006 1013 1019
23. D.H. Harpole Jr., M.M. DeCamp Jr., J. Daley, K. Hur, C.A. Oprian, and W.G. Henderson et al. Prognostic models of thirty-day mortality and morbidity after major pulmonary resection J Thorac Cardiovasc Surg 117 1999 969 979
24. T.E. Strand, H. Rostad, R.A. Damhuis, and J. Norstein Risk factors for 30-day mortality after resection of lung cancer and prediction of their magnitude Thorax 62 2007 991 997